Different requirements for α-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases
- DOI
- 10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8
- Published
- 2001-10
- Container
- European Journal of Immunology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/1521-4141-2001010-31:10-3101::aid-immu3101-3.0.co-2-8,
title = {Different requirements for α-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases},
author = {Claudia Chiodoni and Antonella Stoppacciaro and Sabina Sangaletti and Giorgia Gri and Barbara Cappetti and Yasuhiko Koezuka and Mario P. Colombo},
year = {2001},
journal = {European Journal of Immunology},
doi = {10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8},
url = {https://doi.org/10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8}
}RIS
TY - JOUR TI - Different requirements for α-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases AU - Claudia Chiodoni AU - Antonella Stoppacciaro AU - Sabina Sangaletti AU - Giorgia Gri AU - Barbara Cappetti AU - Yasuhiko Koezuka AU - Mario P. Colombo PY - 2001 JO - European Journal of Immunology DO - 10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8 UR - https://doi.org/10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8 ER -
APA
Chiodoni, C., Stoppacciaro, A., Sangaletti, S., Gri, G., Cappetti, B., Koezuka, Y., & Colombo, M. P. (2001). Different requirements for α-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases. European Journal of Immunology. https://doi.org/10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8
Source records
- crossref · retrieved 2026-09-27T04:30:25.395Z